Elder Pharma weighs sale of nutrition business: sources

MUMBAI Mon May 7, 2012 11:19am IST

Related Topics

Stocks

   

MUMBAI (Reuters) - Drugmaker Elder Pharmaceuticals is exploring options to sell its nutrition products business, two sources with direct knowledge of the development said.

One of the sources said Elder is looking for a valuation of roughly $60 million to $75 million for the business, which includes about 20 brands, and that discussions are at a very early stage.

Elder Pharma Joint Managing Director Alok Saxena denied that the company was looking to sell the business.

"We are not selling anything, nor are we discussing this with anybody," Saxena said in an emailed reply to a query from Reuters.

The nutrition supplements market in India, home to more than 1.3 billion people, is relatively undeveloped and valued at about $1 billion, according to the lobby group Federation of Indian Chambers of Commerce and Industry.

A rapidly expanding middle-class, increasing incidence of diabetes and longer life spans are driving demand for nutrition products in India, an opportunity that has caught the attention of multinationals.

Last year, French drugmaker Sanofi's (SASY.PA) India unit Aventis Pharma AVPH.NS acquired the nutrition business of Universal Medicare for about 5 billion rupees while Danone (DANO.PA) agreed to buy the baby nutrition business of India's Wockhardt (WCKH.NS) for $355 million.

U.S. drugmaker Abbott Laboratories (ABT.N) last week agreed to set up a research and development centre with India's Biocon (BION.NS) to develop affordable nutrition products for the domestic market.

"The talks are only at consideration stage and this business is a small division for Elder," a second source said.

Both sources declined to be identified because the matter is private.

Elder Pharmaceuticals sells popular nutritional products such as multi-vitamin tablets Eldervit, kidney dietary supplement drug Nephrocaps and Elmecob, a tablet used to support anemia treatment.

(Editing by Ranjit Gangadharan)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Jan Dhan Yojana

REUTERS SHOWCASE

Japan Trip

Japan Trip

Modi eyes breakthrough nuclear pact on Japan trip.  Full Article 

Chance For Reform

Chance For Reform

India's coal crunch - a chance to revamp, reallocate and revive.  Full Article 

E-Commerce

E-Commerce

Ratan Tata invests in online retailer Snapdeal.  Full Article 

Top Priority

Top Priority

Finance minister says food inflation is top priority.  Full Article 

Deal Talk

Deal Talk

Who wants to buy Snapchat? Microsoft, Google, Apple, Alibaba.  Video 

Fresh Funding

Fresh Funding

Tiger Global leads $65 million funding in Indian messaging app Hike.  Full Article 

GDP Preview

GDP Preview

Economy likely grew faster in June quarter: Reuters poll.  Full Article 

Safety Net

Safety Net

SEBI revamps trading safety-net rules.  Full Article 

Fraud Investigation

Fraud Investigation

IMF's Lagarde put under investigation in French fraud case.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage